The Latin America, Middle East and Africa Clinical Nutrition Market is expected to witness market growth of 7.9% CAGR during the forecast period (2020-2026).
Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.
Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, is expected to benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.
The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country is expected to fuel market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.
Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, is expected to benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.
The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country is expected to fuel market growth.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration
- Oral
- Enteral and
- Parenteral
By Application
- Cancer
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders and
- Other Applications
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Nestle S.A.
- Lonza Group AG
- BASF SE
- Ajinomoto Co., Inc.
- Perrigo Company PLC
- Hero Nutritionals, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Clinical Nutrition Market by Route Of Administration
Chapter 5. LAMEA Clinical Nutrition Market by Application
Chapter 6. LAMEA Clinical Nutrition Market by End User
Chapter 7. LAMEA Clinical Nutrition Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Nestle S.A.
- Lonza Group AG
- BASF SE
- Ajinomoto Co., Inc.
- Perrigo Company PLC
- Hero Nutritionals, Inc.
Methodology
LOADING...
